Blood test could unmask silent heart failure in diabetics

NCT ID NCT05705869

Ongoing Diagnosis Sponsor: NHS Greater Glasgow and Clyde Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a blood test for NT-proBNP can spot undiagnosed heart failure in 706 people with diabetes who are at high risk. Those with elevated levels get a heart ultrasound and exam. The goal is to see if this screening strategy leads to more early diagnoses and proper treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: NT-proBNP blood test
What this could lead to: If successful, this screening approach could help doctors find hidden heart failure earlier in people with diabetes, allowing for timely treatment and better outcomes.
What could go wrong: This is a diagnostic study, not a treatment trial. The screening may not catch all cases, and some people may have false positives or negatives. Results need further validation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder diabetes mellitus heart failure type 1 diabetes mellitus type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES DIABETES MELLITUS HEART FAILURE TYPE 1 DIABETES TYPE 2 DIABETES

Blood test could unmask silent heart failure in diabetics

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions